Patents by Inventor Andrew P Levine

Andrew P Levine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944611
    Abstract: The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: April 2, 2024
    Assignee: Gilead Sciences, Inc.
    Inventors: Laura Elizabeth Bauer, Anna Chiu, Eric M. Gorman, Andrew Stephen Mulato, Martin Sunkwang Rhee, Charles William Rowe, Scott P. Sellers, Dimitrios Stefanidis, Winston C. Tse, Stephen R. Yant, Dana J. Levine
  • Patent number: 7778896
    Abstract: An electronic DR conversion system includes a DR authority that interfaces with investors through the investor's order management system. When an investor has purchased or sold ordinary shares in a local market and wishes to convert them to, or cancel DRs, the investor can so instruct the DR authority. The DR authority will automatically obtain a foreign exchange rate for the transaction and compute a pass through cost, which is displayed to the investor via their order management system. If the investor accepts the pass through cost, then the DR authority can be configured to automatically issue a plurality of directions to the computer systems of various entities that will be involved in the issuance or cancellation process.
    Type: Grant
    Filed: December 3, 2002
    Date of Patent: August 17, 2010
    Assignee: BNY ConvergEx Group LLC
    Inventor: Andrew P Levine
  • Publication number: 20040107156
    Abstract: An electronic DR conversion system includes a DR authority that interfaces with investors through the investor's order management system. When an investor has purchased or sold ordinary shares in a local market and wishes to convert them to, or cancel DRs, the investor can so instruct the DR authority. The DR authority will automatically obtain a foreign exchange rate for the transaction and compute a pass through cost, which is displayed to the investor via their order management system. If the investor accepts the pass through cost, then the DR authority can be configured to automatically issue a plurality of directions to the computer systems of various entities that will be involved in the issuance or cancellation process.
    Type: Application
    Filed: December 3, 2002
    Publication date: June 3, 2004
    Inventor: Andrew P. Levine